ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 281383 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 281383; 2) Community: the network communities that were significantly associated with the response to NSC 281383; 3) Molecule: the relationships between components within communities and NSC 281383; 4) MDR: the compounds that were significantly associated with the NSC 281383.

NSC Compound Enrichment Correlation
NSC 761130 (E)-6-chloro-3-((2-(4-fluorophenyl)imidazo[1,2-a]pyridin-3-yl)methylene)indolin-2-one 0.0199123109106645 0.74700114
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0209467683758286 0.41134002
NSC 13151 Null 0.0209467683758286 0.36953053
NSC 154948 M-AMSA 0.0209467683758286 0.19404281
NSC 23925 Null 0.0209467683758286 0.25180038
NSC 244404 Null 0.0209467683758286 0.15771168
NSC 267713 Digitoxigenin glycoside 0.0209467683758286 -0.097999307
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0209467683758286 0.24238798
NSC 300289 Pinafide 0.0209467683758286 0.24468668
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0209467683758286 0.26705991
Total:101  Current:51    [First] [Prev] [Next] [Last]